New scientific conference 'Aspirin in the 21st Century' to be held in London

Aug 20 2015

What more can be said about aspirin, a medicine that was first prescribed at the end of the 19th century? It is known and accepted in every country. For over a hundred years it has been the standard by which all other, newer, painkillers have had to be judged, and it has never been found to be inferior. It is still considered the world's leading analgesic.

For forty years it has also been the standard treatment for the prevention and treatment of heart attacks. Its effect on preventing and minimising intra-arterial clotting won the researchers, who discovered its effects on platelets, the Nobel Prize. A daily 75mg dose of aspirin has saved countless lives.

But that is all old news. Can there be anything more to say about aspirin's properties and its use in diseases other than pain, inflammation and thrombosis?

The answer is certainly yes. Come to the 2015 Scientific Conference 'Aspirin in the 21st Century' to be held at the Caledonian Club in London on Friday 28th August, and be prepared to be astonished by the current research into its uses for both prevention and treatment, and its already established benefits, in diseases as diverse as toxaemia of pregnancy, cancer (specifically colorectal), diabetes and HIV.

The Chair Prof Peter Rothwell MD, PhD, FRCP, FMedSci, Action Research Professor of Neurology, University of Oxford, and international distinguished speakers will share their knowledge and explain their work.

In addition The International Aspirin Foundation will announce the winner of their inaugural Junior Investigator Science Award.